On June 7, Gelunhui reported that Zhejiang Dayang Biotech Group (stock code: 003017.SZ) announced that as of the date of this announcement, the remaining 2,422,168 shares of the company's stocks held by employees under the 2022 employee shareholding plan (accounting for 2.8835% of the total share capital of the company) have been sold through centralized bidding trading.
大洋生物(003017.SZ)：2022年员工持股计划股份出售完毕
Zhejiang Dayang Biotech Group (003017.SZ): Employee stock ownership plan share sales completed in 2022.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.